Stem cell transplant trial results

On 30 January the Lancet Neurologypublished the results of a trial involving stem cell transplantation in people with relapsing remitting multiple sclerosis (MS).

The results of the Chicago study of around 20 people show that the treatment halted progression of disability and could potentially reverse the damage caused in MS.

Dr Doug Brown, Research Manager at the MS Society, said: "These are very encouraging results and it's exciting to see that in this trial not only is progression of disability halted, but damage appears to be reversed. The challenge we now face is proving their effectiveness in trials involving large numbers of people."

sitemap | cookie policy | privacy policy | accessibility statement